EyeGene,Inc
Develops gene/cell therapies for age-related diseases and preventive vaccines.
185490 | KO
Overview
Corporate Details
- ISIN(s):
- KR7185490000
- LEI:
- Country:
- South Korea
- Address:
- 경기도 의왕시 양지편2로 13 2층, 의왕시
- Website:
- https://eyegene.co.kr/en/
Description
EyeGene, Inc. is a clinical-stage biopharmaceutical company that researches and develops innovative therapeutics, with a primary focus on gene and cell therapy for age-related diseases. The company's pipeline includes EG-Mirotin, a treatment candidate for non-proliferative diabetic retinopathy and dry age-related macular degeneration. EyeGene is also developing preventive vaccines, such as EG-HPV for cervical cancer, utilizing its proprietary EG-Vac adjuvant system to enhance vaccine efficacy. The company is dedicated to creating transformative treatments by advancing biomedical science.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2022-03-03 00:00 |
[기재정정]주주총회소집결의
|
Korean | 14.9 KB | ||
| 2022-03-02 00:00 |
주주총회소집결의
|
Korean | 11.8 KB | ||
| 2022-03-02 00:00 |
주주총회소집공고
|
Korean | 214.3 KB | ||
| 2022-02-24 00:00 |
투자판단관련주요경영사항(대상포진 백신 EG-HZ 국내 기술이전 계약 체결)
|
Korean | 11.4 KB | ||
| 2022-02-23 00:00 |
매출액또는손익구조30%(대규모법인은15%)이상변동
|
Korean | 11.1 KB | ||
| 2022-02-21 00:00 |
투자판단관련주요경영사항(아이진 mRNA 기반 코로나-19 예방백신 (EG-COVID) 호주 부스터 임상 제 1/2a상 시험 계획 승인)
|
Korean | 13.5 KB | ||
| 2022-02-08 00:00 |
기타경영사항(자율공시)([국책과제 선정] 코로나19 치료제.백신 개발 - 코로나 19 백신 임상 지원)
|
Korean | 8.8 KB | ||
| 2022-02-03 00:00 |
투자판단관련주요경영사항(mRNA 기반 코로나-19 예방백신 (EG-COVID) 부스터 임상 제 1/2a상 시험 계획 남아프리카공화국 신청)
|
Korean | 12.9 KB | ||
| 2022-01-05 00:00 |
투자판단관련주요경영사항(아이진 mRNA 기반 코로나-19 예방백신 (EG-COVID) 호주 부스터 임상 제 1/2a상 시험 계획 신청 )
|
Korean | 12.0 KB | ||
| 2021-12-15 00:00 |
주주명부폐쇄기간또는기준일설정
|
Korean | 4.1 KB | ||
| 2021-11-15 00:00 |
분기보고서 (2021.09)
|
Korean | 1.1 MB | ||
| 2021-11-15 00:00 |
주식등의대량보유상황보고서(일반)
|
Korean | 87.0 KB | ||
| 2021-10-15 00:00 |
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질 및 양이온성 리포좀을 포함하는 면역증강용 조성물 및 이의 용도)
|
Korean | 9.0 KB | ||
| 2021-10-15 00:00 |
기타경영사항(특허권취득)(자율공시)(면역반응 조절물질을 포함하는 백신 조성물)
|
Korean | 9.9 KB | ||
| 2021-09-24 00:00 |
신주인수권행사
|
Korean | 10.6 KB |
Automate Your Workflow. Get a real-time feed of all EyeGene,Inc filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for EyeGene,Inc
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for EyeGene,Inc via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
